I think just looking at valuations and PE multiples in the top tech and biotech companies in the US you see the gap. Not a questions of smarter etc just factual. I cannot personally see the value and infiniite growth in many companies that have P/I ratios similiar to our P/E ratios in Australian tech but it is what it is.
Ann: AGM Chairman and CEO Presentation, page-41
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.32 |
Change
0.010(0.05%) |
Mkt cap ! $352.1M | |||
| Open | High | Low | Value | Volume |
| $18.30 | $19.00 | $18.00 | $350.4K | 19.10K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 488 | $18.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.32 | 60 | 1 |
View Market Depth
| Last trade - 13.11pm 01/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |